SCHEMBL987680

SCHEMBL987680

NS(=O)(=O)Cc1cnccn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.38
ADORA3 P0DMS8 1/20 0.36
TSHR P16473 1/20 0.36
MC4R P32245 1/20 0.36
ADRA1A P35348 1/20 0.36
MC3R P41968 1/20 0.36
HDAC3 O15379 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
DAO P14920 1/20 0.36
CA2 P00918 6/20 0.35
CA9 Q16790 6/20 0.35
CA1 P00915 5/20 0.35
CA12 O43570 5/20 0.35
CA14 Q9ULX7 5/20 0.35
CYP2C9 P11712 2/20 0.35
NAMPT P43490 2/20 0.35
CA5A P35218 1/20 0.34
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4250361 0.80 XDH (0.41) HSP90AA1ADORA3TSHRMC4RADRA1A
SCHEMBL21826839 0.79 HDAC3 (0.36) HSP90AA1ADORA3TSHRMC4RADRA1A
SCHEMBL2400031 0.79 HSP90AA1 (0.38) HSP90AA1ADORA3TSHRMC4RADRA1A
SCHEMBL31471242 0.79 HDAC3 (0.39) HSP90AA1ADORA3TSHRMC4RADRA1A
SCHEMBL2400023 0.79 HDAC3 (0.36) HSP90AA1ADORA3TSHRMC4RADRA1A
SCHEMBL4481303 0.79 HDAC3 (0.39) HSP90AA1ADORA3TSHRMC4RADRA1A
SCHEMBL30437144 0.79 HSP90AA1 (0.38) HSP90AA1ADORA3TSHRMC4RADRA1A
SCHEMBL25541266 0.76 HDAC3 (0.37) HSP90AA1ADORA3TSHRMC4RADRA1A
SCHEMBL1273093 0.76 HDAC3 (0.34) HSP90AA1ADORA3TSHRMC4RADRA1A
SCHEMBL24367867 0.75 HDAC3 (0.36) HDAC3HDAC1HDAC2HDAC6DAO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113490668-B Compounds and compositions for the treatment of diseases associated with APJ receptor activity 安娜普尔纳生物股份有限公司 2025-02-25 CN disclosed
US-20240336590-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH APJ RECEPTOR ACTIVITY ANNAPURNA BIO, INC. 2024-10-10 US disclosed
EP-4364798-A2 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH APJ RECEPTOR ACTIVITY Annapurna Bio Inc. (US) 2024-05-08 EP disclosed
US-11944622-B2 Compounds and compositions for treating conditions associated with APJ receptor activity ANNAPURNA BIO, INC. (US) 2024-04-02 US disclosed
EP-3860998-B1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH APJ RECEPTOR ACTIVITY ANNAPURNA BIO INC (US) 2023-12-27 EP disclosed
US-11724997-B2 Compounds and compositions for treating conditions associated with APJ receptor activity ANNAPURNA BIO, INC. (US) 2023-08-15 US disclosed
US-11724997-B2 Compounds and compositions for treating conditions associated with APJ receptor activity ANNAPURNA BIO, INC. (US) 2023-08-15 US disclosed
US-11724997-B2 Compounds and compositions for treating conditions associated with APJ receptor activity ANNAPURNA BIO, INC. (US) 2023-08-15 US disclosed
US-20230165854-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH APJ RECEPTOR ACTIVITY SHOUTI INC. 2023-06-01 US disclosed
US-20230165854-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH APJ RECEPTOR ACTIVITY SHOUTI INC. 2023-06-01 US disclosed
CN-112055713-A Compounds and compositions for treating diseases associated with APJ receptor activity 安娜普尔纳生物股份有限公司 2020-12-08 CN disclosed
WO-2020073011-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH APJ RECEPTOR ACTIVITY ANNAPURNA BIO, INC. (US) 2020-04-09 WO disclosed
WO-2020073011-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH APJ RECEPTOR ACTIVITY ANNAPURNA BIO, INC. (US) 2020-04-09 WO disclosed
CN-101970417-A Substituted pyraz inylmethyl sulfonamides for use as. fungicides BASF SE 2011-02-09 CN disclosed
US-20110003691-A1 Substituted Pyrazinylmethyl Sulfonamides For Use As Fungicides BASF SE (DE) 2011-01-06 US disclosed
US-20110003691-A1 Substituted Pyrazinylmethyl Sulfonamides For Use As Fungicides BASF SE (DE) 2011-01-06 US disclosed
EP-2265592-A1 SUBSTITUTED PYRAZ INYLMETHYL SULFONAMIDES FOR USE AS. FUNGICIDES BASF SE (DE) 2010-12-29 EP disclosed
EP-2265592-A1 SUBSTITUTED PYRAZ INYLMETHYL SULFONAMIDES FOR USE AS. FUNGICIDES BASF SE (DE) 2010-12-29 EP disclosed
WO-2009112523-A1 SUBSTITUTED PYRAZ INYLMETHYL SULFONAMIDES FOR USE AS. FUNGICIDES BASF SE (DE) 2009-09-17 WO disclosed
WO-2009112523-A1 SUBSTITUTED PYRAZ INYLMETHYL SULFONAMIDES FOR USE AS. FUNGICIDES BASF SE (DE) 2009-09-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11724997-B2 Compounds and compositions for treating conditions associated with APJ receptor activity APLNR, AGTR1, AGTR2 HSP90AA1 4031/4885ADORA3 240/4885TSHR 1266/4885
US-20240336590-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH APJ RECEPTOR ACTIVITY APLNR, AGTR1, AGTR2 HSP90AA1 4031/4885ADORA3 240/4885TSHR 1266/4885
US-20230165854-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH APJ RECEPTOR ACTIVITY APLNR, AGTR1, AGTR2 HSP90AA1 4043/4885ADORA3 201/4885TSHR 1332/4885
US-20110003691-A1 Substituted Pyrazinylmethyl Sulfonamides For Use As Fungicides PRXL2A, ARSA, PADI1 HSP90AA1 1862/4885ADORA3 602/4885TSHR 751/4885
US-11944622-B2 Compounds and compositions for treating conditions associated with APJ receptor activity APLNR, AGTR1, AGTR2 HSP90AA1 4043/4885ADORA3 201/4885TSHR 1332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.